Skip to main content
. 2020 Jan 22;72(1):46–51. doi: 10.1016/j.ihj.2020.01.004

Table 4.

Comparison of echo index (LVEF) on the first, 40th and 90th days in the four study groups.

Variables The Study Group
p-value
Fib. -F
Fib. +F
Inv. -F
Inv. +F
Mean ± SD Percentile 25/75 Mean ± SD Percentile 25/75 Mean ± SD Percentile 25/75 Mean ± SD Percentile 25/75
LVEF of First Day 35.4 ± 9.5 30.0/40.0 35.0 ± 8.8 30.0/40.0 35.2 ± 9.3 30.0/40.0 33.8 ± 9.7 25.0/40.0 0.567
LVEF of 40th Day 36.2 ± 9.2 30.0/40.0 35.8 ± 9.2 30.0/45.0 37.4 ± 11.3 30.0/50.0 35.5 ± 11.7 25.0/45.0 0.507
LVEF of 90th Day 36.1 ± 9.2 30.0/40.0 35.8 ± 9.2 30.0/45.0 37.8 ± 11.1 30.0/50.0 36.0 ± 11.7 25.0/45.0 0.336
Difference of LVEF(1-40 day) 0.79 ± 2.83 0.00/0.00 0.80 ± 3.59 0.0/5.00 2.14 ± 5.51 0.0/5.00 1.68 ± 5.34 0.0/5.00 0.001
Difference of LVEF(40-90 day) 0.04 ± 0.46 0.00/0.00 0.00 0.00 0.47 ± 1.85 0.00 0.59 ± 1.62 0.00/0.00 0.008
Difference of LVEF(1-90 day) 0.75 ± 2.87 0.00/0.00 0.80 ± 3.59 0.00/5.00 2.61 ± 5.63 0.00/5.00 2.27 ± 5.49 0.00/5.00 0.370

LVEF, left ventricular ejection fraction; (Fib. +F), patients received fibrinolytic therapy with f-QRS; (Fib. –F), patients received fibrinolytic therapy without f-QRS; (Inv. +F), patients received invasive therapy with f-QRS; (Inv. –F), patients received invasive therapy without f-QRS.